Screener
Polaryx Therapeutics, Inc. PLYX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q1 '25 | Q4 '24 | Q3 '24 | ||
|---|---|---|---|---|---|---|
| $3.08M+1,132% | $5.14M+11.3% | $250K— | $4.62M— | —— | ||
| $3.5M— | $5.17M+3.4% | —— | $5M— | —— | ||
| $3.5M— | $5.17M+3.4% | —— | $5M— | —— | ||
| $850K+5,100% | $470K+553% | -$17K+83.0% | $72K— | -$100.25K— | ||
| $1.01M— | $605K+109% | —— | $289K— | —— | ||
| $1.01M— | $605K+109% | —— | $289K— | —— | ||
| —— | $560M0.0% | —— | $560M— | —— | ||
| -$102.18M— | -$99.64M-9.9% | —— | -$90.65M— | —— | ||
| $2.49M-41.5% | $4.57M-3.1% | $4.25M— | $4.71M+269% | —— | ||
| $3.5M— | $5.17M+3.4% | —— | $5M— | —— |
FAQ
- What are Polaryx Therapeutics, Inc.'s total assets?
- Polaryx Therapeutics, Inc. (PLYX) holds $3.5M in total assets.
- How much cash does Polaryx Therapeutics, Inc. have?
- Polaryx Therapeutics, Inc. holds $3.1M in cash and equivalents.
- Can Polaryx Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 3.45 — current assets exceed current liabilities.
- Where does Polaryx Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Polaryx Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.